Abstract
neuroplasticity in humans following ischaemic stroke (27) . Based on the assumption of 63 the existence of this critical period, the SMARTS 2 trial (NCT02292251) (20) is currently 64 investigating the effect of early and intensive therapy on upper extremity motor recovery.
65
Sharing the same research question, the Critical Periods After Stroke Study (CPASS) is a 66 large ongoing randomized controlled trial that focuses on determining the optimal time 67 after stroke for intensive motor training (10). To contribute to the delineation of a temporal 68 structure of stroke recovery in humans, we perform an analysis of individual patient clinical 69 data from 219 subjects with upper-limb hemiparesis, who followed occupational therapy
70
(OT) or a VR-based training protocol using the Rehabilitation Gaming System (RGS) 
Materials and Methods

76
Data Sets
77
In this analysis, we included individual patient data from a set of protocols for the re- 
89
The datasets were divided into 17 conditions depending on the specific characteristics 90 of the patients and the requirements of the treatment provided ( Furthermore, all RGS protocols used by acute and subacute patients, combined RGS-99 based training with supervised OT, while condition 13 tested the application of RGS in a 100 domiciliary setting. Despite these differences, in all RGS conditions the same protocol was 101 used. A formal risk of bias analysis on the primary outcome (i.e., change in the Fugl-Meyer 
where X i (t = 0) refers to the corresponding baseline score. due to the variation in treatment intensity and response rates among protocols (26, 28, 33).
144
We computed a NI value for three-time intervals: pre-, post-assessments, and long-term all the follow-up measures were assigned to the follow-up group.
152
For all tests, statistical significance levels were set at p < .05. 
Results
159
Impact assessment of individual conditions
160
The complete dataset includes 219 stroke survivors assigned to 17 rehabilitation conditions 161 (Table 1) at different stages post-stroke: acute (< 3 weeks), subacute (3 weeks to 6 months),
162
early chronic (6-18 months), and late chronic (> 18 months). We observed significant gains in the clinic on late chronic patients had an impact on UE-FM (condition 15 in Table   176 1, median 3.0 ± 4.1 MAD, p < .01; Figure 1 A however, showed higher inter-individual variability and non-significant gains from the end 186 of the therapy to the follow-up.
187
Revealing an extended critical window for recovery
188
To study the temporal structure of recovery after stroke, we now combine the impact 
238
In line with the previous literature, our data illustrate the correlation of ∆ UE-FM with
239
∆ CAHAI and ∆ BI scores at acute stages (4, 31). However, we found that at chronic stages 240 these scales dissociate, possibly due to the introduction of compensatory mechanisms (31).
241
Altogether, our data support the interpretation of UE-FM as an assessment of recovery 242 of body function and structure that is independent of improvement in the performance of 243 iADLs and closely associated with true neurological repair (22).
244
The results presented in this study do require further investigation for a number of extends beyond 12 months post-stroke, these MCID estimates could be better described as the treatment, and follow-up periods).
316
mal clinically important differences of upper-extremity measures early after stroke.
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